Przychodnia Lekarska KOMED Roman Karaszewski

The clinic focuses on breast cancer, specifically advanced, endocrine‑sensitive, PIK3CA‑mutated, hormone receptor‑positive, HER2‑negative disease, aiming to improve treatment outcomes for patients with this aggressive form of cancer.

• Targeted PI3K inhibition strategies
• Combination therapy with CDK4/6 inhibitors
• Optimizing endocrine therapy sequencing
• Monitoring disease progression and survival benefits

The ongoing studies evaluate the safety and effectiveness of novel agents such as inavolisib together with a CDK4/6 inhibitor and letrozole, aiming to extend time without disease progression. Research is conducted at Przychodnia Lekarska KOMED Roman Karaszewski in Konin, Poland.